GLP Watchdog
The RegisterSemaglutideTirzepatidePeptidesEnforcement

Patient Education

GLP-1 Medicines, Explained

Long guides written for the people taking semaglutide, tirzepatide and everything else in this class. Nothing here is asserted without a source — the FDA, a trial, or peer-reviewed work — and an editor reads every piece before it goes up.

See our editorial methodology and the full central citation registry behind every clinical and regulatory statement we make.

GLP-1 Cost & Insurance Guide

How to actually afford GLP-1 weight loss medications in 2026 — insurance, manufacturer coupons, compounded options, savings hacks, and the math behind every option.

4 articles →

GLP-1 Diet & Lifestyle Guide

How to eat, train, and live well on GLP-1 weight-loss medications — protein targets, foods to avoid, exercise guidance, and evidence-based lifestyle strategies for long-term success.

1 article →

GLP-1 Medications: The Complete Guide

In-depth guides to semaglutide, tirzepatide, and the rest of the GLP-1 family — how they work, dosing, comparisons, and what the clinical evidence actually shows.

7 articles →

GLP-1 Side Effects & Safety

Honest, sourced explanations of GLP-1 side effects, safety data, contraindications, and how to manage symptoms — written for patients, citing FDA and peer-reviewed research.

4 articles →

GLP Watchdog

Independent · Not a government agency

We publish who is allowed to sell GLP‑1s in America, what they actually charge once the billing cycle is applied, and the date we last checked.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

The Register

  • All sellers
  • Seller reviews
  • By pharmacy
  • By drug
  • By state
  • By insurance

Enforcement

  • FDA warning letters
  • Peptide sellers
  • Conditions treated
  • Our corrections

Real prices

  • Live price tracker
  • Unit converter
  • Interaction checker
  • Employer coverage
  • All tools

How we check

  • Methodology
  • Editorial policy
  • How we make money
  • Sources
  • Research
  • Glossary
  • FAQ
  • Site index

Who we are

  • About
  • Editorial team
  • Contact
  • Press
  • Advertise
  • Careers
  • Medical Disclaimer
  • Nature of Reviews
  • Disclosure
  • Code of Conduct
  • Privacy
  • Terms
  • Trademarks

GLP Watchdog is an independent publisher. It is not a government agency, a regulator, or a licensing body, and nothing here is an official determination. The information on this site is for general information only and is not a substitute for professional medical advice, diagnosis, or treatment. Wegovy®, Ozempic®, Rybelsus® and Saxenda® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. All other product names referenced are trademarks of their respective owners. GLP Watchdog is not affiliated with any pharmaceutical manufacturer.

© 2026 GLP Watchdog. All rights reserved.